Showing results (291-300 of 942) with videos related to
Sort By:
Pageof 95
The Journal of Biological Chemistry|April 5, 2000
Selective inhibition of trypsin by (2R,4R)-4-phenyl-1-[Nalpha-(7- methoxy-2-naphthalenesulfonyl)-L-arginyl]-2-piperidinecarboxylic acidA Hijikata-Okunomiya, Y Tamao, R Kikumoto, et al.Biochimica Et Biophysica Acta|June 26, 1992
Biosynthesis of prostaglandins from 17(18)epoxy-eicosatetraenoic acid, a cytochrome P-450 metabolite of eicosapentaenoic acidE H Oliw, S Okamoto, L Hörnsten, et al.Oncogenesis|December 23, 2015
MN1-Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cellsD V Wenge, E Felipe-Fumero, L Angenendt, et al.Blood Cancer Journal|September 17, 2016
MATE1 regulates cellular uptake and sensitivity to imatinib in CML patientsS Harrach, C Schmidt-Lauber, T Pap, et al.International Journal of Oncology|July 26, 2006
Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancerJ C Becker, C Müller-Tidow, M Stolte, et al.Bone Marrow Transplantation|September 19, 2006
Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancerN Frickhofen, W E Berdel, F Opri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancerM Thomas, C Rübe, M Semik, et al.Leukemia|September 10, 2011
NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive miceC I-U Chen, S Koschmieder, L Kerstiens, et al.The Journal of Biological Chemistry|January 15, 1992
Purification and molecular cloning of a butyrolactone autoregulator receptor from Streptomyces virginiaeS Okamoto, T Nihira, H Kataoka, et al.Antimicrobial Agents and Chemotherapy|September 1, 1992
In vitro antibacterial activities of tosufloxacin against and uptake of tosufloxacin by outer membrane mutants of Escherichia coli, Proteus mirabilis, and Salmonella typhimuriumJ Mitsuyama, Y Itoh, M Takahata, et al.Pageof 95